drugset / Trial / NCT06472531
A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer
RandomizedParallel-groupOpen-labelDiagnostic
Summary
Phase I/II study in the management of Healthy Male Subjects and patients with suspected prostate cancer.
Timeline
- Start
- 2024-05-23
- Primary completion
- 2024-09-30
- Completion
- 2024-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INR101 | Diagnostic / imaging agent | 259 mbq | Intravenous |
| Subject | INR101 | Diagnostic / imaging agent | 333 mbq | Intravenous |